Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

BACKGROUND: New biomarkers are needed for the prognosis of advanced colorectal cancer, which remains incurable by conventional treatments. O(6)-methylguanine DNA methyltransferase (MGMT) methylation and protein expression have been related to colorectal cancer treatment failure and tumor progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliver, Jaime Antonio, Ortiz, Raúl, Melguizo, Consolación, Álvarez, Pablo Juan, Gómez-Millán, Jaime, Prados, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227111/
https://www.ncbi.nlm.nih.gov/pubmed/25015560
http://dx.doi.org/10.1186/1471-2407-14-511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227111/
https://www.ncbi.nlm.nih.gov/pubmed/25015560
http://dx.doi.org/10.1186/1471-2407-14-511

Ejemplares similares